These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 23066033)

  • 1. Raf kinase inhibitor RKIP inhibits MDA-9/syntenin-mediated metastasis in melanoma.
    Das SK; Bhutia SK; Sokhi UK; Azab B; Su ZZ; Boukerche H; Anwar T; Moen EL; Chatterjee D; Pellecchia M; Sarkar D; Fisher PB
    Cancer Res; 2012 Dec; 72(23):6217-26. PubMed ID: 23066033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RETRACTED: mda-9/Syntenin regulates the metastatic phenotype in human melanoma cells by activating nuclear factor-kappaB.
    Boukerche H; Su ZZ; Emdad L; Sarkar D; Fisher PB
    Cancer Res; 2007 Feb; 67(4):1812-22. PubMed ID: 17308124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma.
    Notarbartolo M; Labbozzetta M; Pojero F; D'Alessandro N; Poma P
    Curr Mol Med; 2018; 18(9):630-639. PubMed ID: 30608040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
    Aissaoui H; Prévost C; Boucharaba A; Sanhadji K; Bordet JC; Négrier C; Boukerche H
    J Biol Chem; 2015 Feb; 290(6):3333-48. PubMed ID: 25505176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
    Gangemi R; Mirisola V; Barisione G; Fabbi M; Brizzolara A; Lanza F; Mosci C; Salvi S; Gualco M; Truini M; Angelini G; Boccardo S; Cilli M; Airoldi I; Queirolo P; Jager MJ; Daga A; Pfeffer U; Ferrini S
    PLoS One; 2012; 7(1):e29989. PubMed ID: 22267972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src.
    Boukerche H; Su ZZ; Prévot C; Sarkar D; Fisher PB
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15914-9. PubMed ID: 18832467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raf kinase inhibitor protein suppresses nuclear factor-κB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression.
    Beshir AB; Ren G; Magpusao AN; Barone LM; Yeung KC; Fenteany G
    Cancer Lett; 2010 Dec; 299(2):137-49. PubMed ID: 20855151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the integrin effector kinase focal adhesion kinase in cancer cells is regulated by crosstalk between protein kinase Calpha and the PDZ adapter protein mda-9/Syntenin.
    Hwangbo C; Kim J; Lee JJ; Lee JH
    Cancer Res; 2010 Feb; 70(4):1645-55. PubMed ID: 20145126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
    Boukerche H; Aissaoui H; Prévost C; Hirbec H; Das SK; Su ZZ; Sarkar D; Fisher PB
    Oncogene; 2010 May; 29(21):3054-66. PubMed ID: 20228839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
    Kim SO; Kim MR
    Int J Oncol; 2013 Jan; 42(1):349-58. PubMed ID: 23135610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mda-9/Syntenin: a positive regulator of melanoma metastasis.
    Boukerche H; Su ZZ; Emdad L; Baril P; Balme B; Thomas L; Randolph A; Valerie K; Sarkar D; Fisher PB
    Cancer Res; 2005 Dec; 65(23):10901-11. PubMed ID: 16322237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Raf kinase inhibitor protein (RKIP) and phospho-RKIP expression in melanomas.
    Cardile V; Malaponte G; Loreto C; Libra M; Caggia S; Trovato FM; Musumeci G
    Acta Histochem; 2013 Oct; 115(8):795-802. PubMed ID: 23601922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer.
    Yousuf S; Duan M; Moen EL; Cross-Knorr S; Brilliant K; Bonavida B; LaValle T; Yeung KC; Al-Mulla F; Chin E; Chatterjee D
    PLoS One; 2014; 9(3):e92478. PubMed ID: 24658061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.
    Baritaki S; Yeung K; Palladino M; Berenson J; Bonavida B
    Cancer Res; 2009 Nov; 69(21):8376-85. PubMed ID: 19843864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raf Kinase Inhibitor Protein (RKIP) Inhibits Tumor Necrosis Factor-α (TNF-α) Induced Adhesion Molecules Expression in Vascular Smooth Muscle Bells by Suppressing (Nuclear Transcription Factor-κB (NF-kappaB) Pathway.
    Jing SH; Gao X; Yu B; Qiao H
    Med Sci Monit; 2017 Oct; 23():4789-4797. PubMed ID: 28983072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.
    Datar I; Feng J; Qiu X; Lewandowski J; Yeung M; Ren G; Aras S; Al-Mulla F; Cui H; Trumbly R; Arudra SK; De Las Casas LE; de la Serna I; Bitar MS; Yeung KC
    PLoS One; 2015; 10(8):e0134494. PubMed ID: 26308852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.
    Schuierer MM; Bataille F; Hagan S; Kolch W; Bosserhoff AK
    Cancer Res; 2004 Aug; 64(15):5186-92. PubMed ID: 15289323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RKIP downregulates B-Raf kinase activity in melanoma cancer cells.
    Park S; Yeung ML; Beach S; Shields JM; Yeung KC
    Oncogene; 2005 May; 24(21):3535-40. PubMed ID: 15782137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
    Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
    Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.